These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2495602)

  • 1. Effects of donor splenocytes treated with mitomycin C on rat hepatic, cardiac, and intestinal allografts.
    Bollinger RB; Yamaguchi Y; Harland RC; Wyble C; Mori K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):213-4. PubMed ID: 2495602
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: analysis of the immune status.
    Yamaguchi Y; Mori K; Bollinger RR
    J Clin Lab Immunol; 1990 Jun; 32(2):59-66. PubMed ID: 1967040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable allograft responses to pretreatment with donor splenocytes treated with mitomycin C in the rat.
    Yamaguchi Y; Harland R; Wyble C; Mori K; Bollinger RR
    Transplantation; 1989 Feb; 47(2):360-3. PubMed ID: 2493180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: tissue distribution of donor class I major histocompatibility complex antigen-positive cells in the recipient.
    Goto M; Yamaguchi Y; Hamaguchi H; Hisama N; Miyanari N; Ichiguchi O; Mori K; Shirakusa T; Ogawa M
    Transplant Proc; 1995 Apr; 27(2):1625-7. PubMed ID: 7725428
    [No Abstract]   [Full Text] [Related]  

  • 5. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: the distribution of donor class I-positive cells in the recipient.
    Goto M; Yamaguchi Y; Matsuno K; Takata N; Makino Y; Kikuchi N; Hamaguchi H; Hisama N; Otsuka Y; Mori K
    Transplant Proc; 1993 Apr; 25(2):1893-5. PubMed ID: 8470217
    [No Abstract]   [Full Text] [Related]  

  • 6. Permanent rat cardiac allograft survival induced by ultraviolet B-irradiated donor lymphocytes and peritransplant cyclosporine.
    Oluwole SF; Fawwaz RA; Reemtsma K; Hardy MA
    Surgery; 1988 Aug; 104(2):231-8. PubMed ID: 2969630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged survival of hepatic and cardiac allografts by i.v. injection of donor spleen cells following splenectomy in rats: possible mechanisms involved in tolerance induced by intraportal injection of donor antigens.
    Nagano H; Monden M; Gotoh M; Tanigawa T; Nakano Y; Tono T; Mori T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):352-3. PubMed ID: 8438331
    [No Abstract]   [Full Text] [Related]  

  • 8. Different response of intestinal and cardiac allografts to pretreatment with UV-B irradiated donor-specific leukocytes (DL) or DL alone.
    Gundlach M; Oluwole SF; Pohland CC; Broelsch CE; Hardy MA
    Transplant Proc; 1996 Oct; 28(5):2482-3. PubMed ID: 8907913
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of portal venous tolerance on the survival of small bowel allografts in the rat.
    Nakafusa Y; Goss JA; Roland CR; Flye MW
    Transplantation; 1993 Nov; 56(5):1279-82. PubMed ID: 8249139
    [No Abstract]   [Full Text] [Related]  

  • 10. Donor-specific tolerance to cardiac, but not renal, allografts is induced by intrathymic transfer of donor splenocytes.
    Nakafusa Y; Goss JA; Flye MW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):292-4. PubMed ID: 8438305
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of donor-specific tolerance to rat cardiac and small bowel allografts by intrathymic inoculation of donor T-cells.
    Chowdhury NC; Fawwaz RA; Oluwole SF
    J Surg Res; 1993 Apr; 54(4):368-74. PubMed ID: 8331931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
    Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
    Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in donor-specific cytotoxic T lymphocytes and prolonged cardiac allograft survival following intrathymic donor splenocyte injection.
    Goss JA; Nakafusa Y; Yu S; Flye MW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):286-8. PubMed ID: 8438302
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential effect of portal venous tolerance on survival of vascularized organ allografts.
    Nakafusa Y; Goss JA; Roland CR; Flye MW
    Transplant Proc; 1994 Jun; 26(3):1621. PubMed ID: 8030061
    [No Abstract]   [Full Text] [Related]  

  • 15. Donor intrathymic injection with recipient splenocytes allows indefinite survival following small bowel transplantation in a rat graft-vs-host disease model.
    Blakely ML; Shaffer D; Ohzato H; Gottschalk R; Van der Werf WJ; Monaco AP
    Transplant Proc; 1994 Jun; 26(3):1582. PubMed ID: 8030046
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of passenger leukocytes in the immunogenicity of intestinal and cardiac allografts in the rat.
    Gundlach M; Oluwole S; D'Agati V; Chabot J; Broelsch CE; Hardy MA
    Transplant Proc; 1992 Jun; 24(3):1131-2. PubMed ID: 1604552
    [No Abstract]   [Full Text] [Related]  

  • 17. Donor-type blood and immunoadjuvant-induced accelerated cardiac allograft rejection: a rat model.
    Takahara S; Jiang H; Takano Y; Kameoka H; Kokado Y; Ishibashi M; Jiang Y; Moutabarrik A; Okuyama A; Sonoda T
    Transplant Proc; 1992 Oct; 24(5):1659-60. PubMed ID: 1412787
    [No Abstract]   [Full Text] [Related]  

  • 18. Portal tolerance in rats: effect of donor cell treatment and timing of administration.
    Tanigawa T; Monden M; Nagano H; Hasuike Y; Gotoh M; Fukuzaki T; Ota H; Yoshida T; Mori T
    Transplant Proc; 1994 Aug; 26(4):1870-1. PubMed ID: 8066608
    [No Abstract]   [Full Text] [Related]  

  • 19. Survival of rat small bowel allografts treated with allotrap 07R.
    Tice DG; Bruch D; Buelow R; Squiers EC
    J Surg Res; 1997 Sep; 72(1):78-83. PubMed ID: 9344717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: in situ splenic distribution of donor class I major histocompatibility complex antigen-positive cells in the recipient.
    Goto M; Yamaguchi Y; Matsuno K; Takata N; Makino Y; Kikuchi N; Hamaguchi H; Hisama N; Miyanari N; Mori K; Ogawa M
    J Surg Res; 1996 Jan; 60(1):216-23. PubMed ID: 8592417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.